These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 8320163

  • 1. Strong inhibition of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole-induced mutagenesis and hepatocarcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone.
    Hirose M, Akagi K, Hasegawa R, Satoh T, Nihro Y, Miki T, Sugimura T, Ito N.
    Jpn J Cancer Res; 1993 May; 84(5):481-4. PubMed ID: 8320163
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Hirose M, Hasegawa R, Kimura J, Akagi K, Yoshida Y, Tanaka H, Miki T, Satoh T, Wakabayashi K, Ito N.
    Carcinogenesis; 1995 Dec; 16(12):3049-55. PubMed ID: 8603484
    [Abstract] [Full Text] [Related]

  • 3. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).
    Hirose M, Iwata S, Ito E, Nihro Y, Takahashi S, Mizoguchi Y, Miki T, Satoh T, Ito N, Shirai T.
    Carcinogenesis; 1995 Sep; 16(9):2227-32. PubMed ID: 7554080
    [Abstract] [Full Text] [Related]

  • 4. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
    Hirose M, Futakuchi M, Tanaka H, Orita SI, Ito T, Miki T, Shirai T.
    Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
    [Abstract] [Full Text] [Related]

  • 5. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis.
    Hirose M, Takahashi S, Ogawa K, Futakuchi M, Shirai T.
    Food Chem Toxicol; 1999 Feb; 37(9-10):985-92. PubMed ID: 10541455
    [Abstract] [Full Text] [Related]

  • 6. Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis.
    Hirose M, Ito T, Takahashi S, Ozaki M, Ogiso T, Nihro Y, Miki T, Shirai T.
    Eur J Cancer Prev; 1998 Jun; 7(3):233-41. PubMed ID: 9696932
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
    Futakuchi M, Hirose M, Miki T, Tanaka H, Ozaki M, Shirai T.
    Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778
    [Abstract] [Full Text] [Related]

  • 8. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats.
    Hirose M, Akagi K, Hasegawa R, Yaono M, Satoh T, Hara Y, Wakabayashi K, Ito N.
    Carcinogenesis; 1995 Feb; 16(2):217-21. PubMed ID: 7859351
    [Abstract] [Full Text] [Related]

  • 9. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats.
    Hirose M, Takahashi S, Ogawa K, Futakuchi M, Shirai T, Shibutani M, Uneyama C, Toyoda K, Iwata H.
    Cancer Lett; 1999 Sep 01; 143(2):173-8. PubMed ID: 10503899
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic alterations in HCA-induced tumors.
    Ushijima T, Makino H, Kakiuchi H, Inoue R, Sugimura T, Nagao M.
    Princess Takamatsu Symp; 1995 Sep 01; 23():281-91. PubMed ID: 8844820
    [Abstract] [Full Text] [Related]

  • 17. Suppression of chemical carcinogenesis by water-soluble organosulfur compounds.
    Fukushima S, Takada N, Wanibuchi H, Hori T, Min W, Ogawa M.
    J Nutr; 2001 Mar 01; 131(3s):1049S-53S. PubMed ID: 11238814
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N, Hasegawa R, Shirai T, Fukushima S, Hakoi K, Takaba K, Iwasaki S, Wakabayashi K, Nagao M, Sugimura T.
    Carcinogenesis; 1991 May 01; 12(5):767-72. PubMed ID: 2029739
    [Abstract] [Full Text] [Related]

  • 19. Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin.
    Firdous AP, Sindhu ER, Ramnath V, Kuttan R.
    Asian Pac J Cancer Prev; 2010 May 01; 11(6):1795-800. PubMed ID: 21338235
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of hepatocellular carcinoma development and erythrocyte polyamine levels in ODS rats fed on 3'-methyl-4-dimethylaminoazobenzene by hemicalcium ascorbate, 2-O-octadecylascorbic acid, and ascorbyl palmitate.
    Shimpo K, Takahashi H, Tsuda H, Hibino T, Kawai K, Kimura C, Nagatsu T, Fujita K.
    Cancer Detect Prev; 1996 May 01; 20(2):137-45. PubMed ID: 8706039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.